1. Home
  2. ATAI vs WSBF Comparison

ATAI vs WSBF Comparison

Compare ATAI & WSBF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATAI
  • WSBF
  • Stock Information
  • Founded
  • ATAI 2018
  • WSBF 1921
  • Country
  • ATAI Germany
  • WSBF United States
  • Employees
  • ATAI N/A
  • WSBF N/A
  • Industry
  • ATAI Biotechnology: Pharmaceutical Preparations
  • WSBF Savings Institutions
  • Sector
  • ATAI Health Care
  • WSBF Finance
  • Exchange
  • ATAI Nasdaq
  • WSBF Nasdaq
  • Market Cap
  • ATAI 282.6M
  • WSBF 233.0M
  • IPO Year
  • ATAI 2021
  • WSBF N/A
  • Fundamental
  • Price
  • ATAI $1.41
  • WSBF $12.42
  • Analyst Decision
  • ATAI Strong Buy
  • WSBF
  • Analyst Count
  • ATAI 3
  • WSBF 0
  • Target Price
  • ATAI $10.50
  • WSBF N/A
  • AVG Volume (30 Days)
  • ATAI 1.4M
  • WSBF 61.4K
  • Earning Date
  • ATAI 05-19-2025
  • WSBF 04-22-2025
  • Dividend Yield
  • ATAI N/A
  • WSBF 4.82%
  • EPS Growth
  • ATAI N/A
  • WSBF 95.86
  • EPS
  • ATAI N/A
  • WSBF 1.02
  • Revenue
  • ATAI $308,000.00
  • WSBF $133,551,000.00
  • Revenue This Year
  • ATAI $65.58
  • WSBF N/A
  • Revenue Next Year
  • ATAI N/A
  • WSBF N/A
  • P/E Ratio
  • ATAI N/A
  • WSBF $12.05
  • Revenue Growth
  • ATAI N/A
  • WSBF 1.81
  • 52 Week Low
  • ATAI $1.03
  • WSBF $11.61
  • 52 Week High
  • ATAI $2.57
  • WSBF $16.86
  • Technical
  • Relative Strength Index (RSI)
  • ATAI 44.57
  • WSBF 48.66
  • Support Level
  • ATAI $1.36
  • WSBF $12.18
  • Resistance Level
  • ATAI $1.54
  • WSBF $12.50
  • Average True Range (ATR)
  • ATAI 0.09
  • WSBF 0.31
  • MACD
  • ATAI -0.00
  • WSBF 0.08
  • Stochastic Oscillator
  • ATAI 0.00
  • WSBF 66.67

About ATAI ATAI Life Sciences N.V.

ATAI Life Sciences NV is a clinical-stage biopharmaceutical company on a mission to develop effective mental health treatments to transform patient outcomes. The company's pipeline of psychedelic-based therapies includes VLS-01 (buccal film DMT) for treatment-resistant depression (TRD) and EMP-01 (oral R-MDMA) for social anxiety disorder. It is also advancing a drug discovery program to identify novel, non-hallucinogenic 5-HT2AR agonists for TRD.

About WSBF Waterstone Financial Inc. (MD)

Waterstone Financial Inc is a holding company. Through its subsidiaries, It operates in two segments: Community Banking and Mortgage Banking. The community banking segment provides consumer and business banking products and services to customers, which include various types of loans, deposits, and personal investment services. The Mortgage Banking segment involves residential mortgage loans for the primary purpose of sale in the secondary market. The vast majority of its revenue comes from the community banking segment.

Share on Social Networks: